Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation.
作者信息
Moreno Raul, Fernandez Cristina, Sanchez-Recalde Angel, Calvo Luis, Galeote Guillermo, Sanchez-Aquino Rosa, Lopez-Sendon Jose-Luis
出版信息
Br J Clin Pharmacol. 2007 Jul;64(1):110-2. doi: 10.1111/j.1365-2125.2006.02840.x.
Abstract
摘要
相似文献
1
Risk of stent thrombosis after sirolimus or paclitaxel eluting coronary stent implantation.西罗莫司或紫杉醇洗脱冠状动脉支架植入术后支架血栓形成的风险。
Br J Clin Pharmacol. 2007 Jul;64(1):110-2. doi: 10.1111/j.1365-2125.2006.02840.x.
2
3
A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus 2-year clinical outcomes of the DES-DIABETES trial.糖尿病患者西罗莫司洗脱支架与紫杉醇洗脱支架植入的随机对照比较：DES-DIABETES试验的2年临床结果
J Am Coll Cardiol. 2009 Mar 3;53(9):812-3. doi: 10.1016/j.jacc.2008.11.028.
4
[Late thrombosis of a drug-eluting coronary stent after antiplatelet therapy discontinuation].[停用抗血小板治疗后药物洗脱冠状动脉支架的晚期血栓形成]
Ann Fr Anesth Reanim. 2005 Oct;24(10):1275-7. doi: 10.1016/j.annfar.2005.07.075. Epub 2005 Aug 24.
5
Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study.西罗莫司洗脱支架与紫杉醇洗脱支架在同一例患有多处冠状动脉病变的糖尿病患者中的头对头比较：一项前瞻性、随机、多中心研究。
Diabetes Care. 2008 Jan;31(1):15-9. doi: 10.2337/dc07-1377. Epub 2007 Oct 1.
6
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).西罗莫司洗脱支架、紫杉醇洗脱支架和裸金属支架置入后的临床结局（来自前瞻性多中心德国DES.DE注册研究的第一阶段）
Am J Cardiol. 2009 Nov 15;104(10):1362-9. doi: 10.1016/j.amjcard.2009.06.058. Epub 2009 Sep 26.
7
Two-year (mid-term) results for unprotected left main coronary artery percutaneous interventions with drug-eluting stents.药物洗脱支架用于无保护左主干冠状动脉经皮介入治疗的两年（中期）结果
Indian Heart J. 2008 May-Jun;60(3):195-9.
8
Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.糖尿病患者植入西罗莫司或紫杉醇药物洗脱冠状动脉支架后的冠状动脉支架内再狭窄
Diabetes Metab. 2008 Feb;34(1):62-7. doi: 10.1016/j.diabet.2007.09.002.
9
Drug-eluting coronary stents: many meta-analyses, little benefit.药物洗脱冠状动脉支架：众多荟萃分析，获益寥寥。
Prescrire Int. 2009 Apr;18(100):70-4.
10
Five-year outcomes of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: are they equally good (or bad)?西罗莫司洗脱支架和紫杉醇洗脱支架在常规临床实践中的五年结果：它们同样好（或差）吗？
Circulation. 2011 Jun 21;123(24):2779-81. doi: 10.1161/CIRCULATIONAHA.111.033654. Epub 2011 Jun 6.
引用本文的文献
1
Histopathological evaluation of a retinoic acid eluting stent in a rabbit iliac artery model.兔髂动脉模型中雷帕霉素洗脱支架的组织病理学评价。
Sci Rep. 2022 Aug 3;12(1):13305. doi: 10.1038/s41598-022-16025-5.
2
eG Coated Stents Exhibit Enhanced Endothelial Wound Healing Characteristics.载雷帕霉素可降解聚合物涂层支架具有促进内皮细胞愈合的特性。
Cardiovasc Eng Technol. 2021 Oct;12(5):515-525. doi: 10.1007/s13239-021-00542-x. Epub 2021 May 18.
3
Three year follow-up of the sirolimus-eluting stent and the paclitaxel-eluting stent in daily practice.在日常实践中，对西罗莫司洗脱支架和紫杉醇洗脱支架进行 3 年随访。
Clin Cardiol. 2009 Dec;32(12):E63-7. doi: 10.1002/clc.20550.
本文引用的文献
1
A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.一项比较Cypher支架和Taxus支架用于阻塞性冠状动脉疾病患者的试验的荟萃分析。
Br J Clin Pharmacol. 2006 Jun;61(6):720-6. doi: 10.1111/j.1365-2125.2006.02614.x.
2
Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.西罗莫司洗脱支架与紫杉醇洗脱支架治疗冠状动脉初发病变的随机对照试验：REALITY试验
JAMA. 2006 Feb 22;295(8):895-904. doi: 10.1001/jama.295.8.895.
3
Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.紫杉醇和西罗莫司洗脱支架在小冠状动脉血管中的随机试验。
Eur Heart J. 2006 Feb;27(3):260-6. doi: 10.1093/eurheartj/ehi721. Epub 2006 Jan 9.
4
Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.一项关于非聚合物雷帕霉素洗脱支架与聚合物紫杉醇洗脱支架减少晚期管腔丢失的随机试验。
Circulation. 2006 Jan 17;113(2):273-9. doi: 10.1161/CIRCULATIONAHA.105.575977. Epub 2006 Jan 3.
5
Drug eluting stents: an updated meta-analysis of randomised controlled trials.药物洗脱支架：随机对照试验的最新荟萃分析
Heart. 2006 May;92(5):641-9. doi: 10.1136/hrt.2005.061622. Epub 2005 Oct 10.
6
Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).在真实临床环境中药物洗脱支架与第三代裸金属支架相比的增量成本效益：随机巴塞尔支架成本效益试验（BASKET）
Lancet. 2005;366(9489):921-9. doi: 10.1016/S0140-6736(05)67221-2.
7
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.紫杉醇洗脱支架或西罗莫司洗脱支架预防糖尿病患者再狭窄
N Engl J Med. 2005 Aug 18;353(7):663-70. doi: 10.1056/NEJMoa044372. Epub 2005 Aug 16.
8
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.用于冠状动脉血运重建的西罗莫司洗脱支架和紫杉醇洗脱支架。
N Engl J Med. 2005 Aug 18;353(7):653-62. doi: 10.1056/NEJMoa051175. Epub 2005 Aug 16.
9
[Drug-eluting stents and other anti-restenosis devices].药物洗脱支架及其他抗再狭窄装置
Rev Esp Cardiol. 2005 Jul;58(7):842-62.
10
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.药物洗脱支架血栓形成：一项纳入10项随机研究的汇总分析结果
J Am Coll Cardiol. 2005 Mar 15;45(6):954-9. doi: 10.1016/j.jacc.2004.11.065.
Zotero 插件